Drug profile · INN
danaparoid sodium
ORGARAN
danaparoid sodium (ORGARAN) is a antithrombin-iii activator. Route of administration: injection. Current US regulatory status: approved.
Drug details — danaparoid sodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
danaparoid sodium (ORGARAN) is a antithrombin-iii activator. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Antithrombin-III activator
Primary target: Antithrombin-III
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is danaparoid sodium?
danaparoid sodium (ORGARAN) is a antithrombin-iii activator. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for danaparoid sodium?
ORGARAN is a marketed brand name for danaparoid sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of danaparoid sodium?
danaparoid sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.